Tomas Zamora
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tomas Zamora has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Eduardo Botello
Department of Orthopaedic Surgery. Pontificia Universidad Catolica de Chile, Santiago, Chile
7 shared publications- Eduardo Botello
Department of Orthopaedic Surgery, Pontificia Universidad Católica de Chile, Santiago, Chile
5 shared publications Daniel Schweitzer
Department of Orthopedic Surgery, School of Medicine, Pontificia Universidad Catolica de Chile, Diagonal Paraguay 362, 3rd floor, Santiago 8330077, Chile
4 shared publicationsIaniv Klaber
Pontificia Universidad Católica de Chile
4 shared publicationsClara Schulze S
Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
2 shared publicationsFrancisco Linares
Departamento de Ortopedia, Pontificia Universidad Javeriana
2 shared publications
Latest Publications
- Open Access
- 22 January 2026
- Published by EDP Sciences in SICOT-J
- Vol. 12, 2
What’s new on giant cell tumor of bone
When treating extremities affected by giant cell tumor of bone (GCTB), curettage should be performed to preserve the joint as much as possible in order to obtain a good functional outcome. The local recurrence risk is high following curettage, but new techniques are being developed to reduce local recurrence. We present a review of the literature reporting favorable results of radiofrequency ablation alone in locally recurrent small GCTB. New filling materials are also being developed to prevent non-oncological complications such as arthrosis and fractures. Routine measurement of tartrate-resistant acid phosphatase 5b in serum may be helpful in detecting early instances of local recurrence. For unresectable or metastatic GCTB, there is an urgent need for a new drug that is as effective as denosumab, avoids side effects, and can be administered to pregnant women.
- 22 January 2026
- Published by EDP Sciences in SICOT-J
- Vol. 12, 2
Open AccessWhat’s new on giant cell tumor of bone
When treating extremities affected by giant cell tumor of bone (GCTB), curettage should be performed to preserve the joint as much as possible in order to obtain a good functional outcome. The local recurrence risk is high following curettage, but new techniques are being developed to reduce local recurrence. We present a review of the literature reporting favorable results of radiofrequency ablation alone in locally recurrent small GCTB. New filling materials are also being developed to prevent non-oncological complications such as arthrosis and fractures. Routine measurement of tartrate-resistant acid phosphatase 5b in serum may be helpful in detecting early instances of local recurrence. For unresectable or metastatic GCTB, there is an urgent need for a new drug that is as effective as denosumab, avoids side effects, and can be administered to pregnant women.
- 1 September 2025
- Published by Springer Nature
- p. 295-303
Low-Grade Periprosthetic Infections
- 21 March 2025
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 35 (1) , 1-9
Surgical dislocation of the hip without trochanteric osteotomy for the treatment of bone tumors around the hip
Purpose Bone tumors around the hip pose significant surgical challenges. While surgical dislocation with a trochanteric flip osteotomy through a posterior approach is commonly used, it is associated with known complications. This study is the first to report outcomes using surgical hip dislocation without a trochanteric osteotomy for this purpose. We evaluated early to long-term outcomes of this approach and compared results between patients undergoing extensive curettage with adjuvants and those undergoing simple excision. Methods Sixteen patients (18 hips) with benign or intermediate bone and synovial tumors were treated using surgical dislocation without a trochanteric flip osteotomy. Patients had a minimum follow-up of 12 months (median 3.6 years, range 1–11 years). Outcomes included local recurrence, complications, functionality, and quality of life (QoL) assessed with SF-12 (mental and physical components), HOOS, TESS, and MSTS scores. Comparative analysis was performed between extensive curettage with adjuvancy and simple excision. Results All procedures were completed successfully without any local recurrences or significant complications. Patients had a median hospital stay of 3 days (ranging from 1 to 4 days), and the median follow-up duration was 3.6 years (ranging from 1 to 13 years). The mean SF-12 physical and mental health scores were 51 and 42, respectively. Additionally, the scores for HOOS, MSTS, and TESS were 74, 77%, and 86%, respectively. One patient (6%) developed osteoarthritis, while three (17%) experienced lateral hip pain managed conservatively. No significant differences were found in complications, functionality, or QoL between the extensive curettage and simple excision groups. Conclusion Surgical dislocation of the hip without trochanteric osteotomy is a safe and effective alternative for excising tumors around the hip. It provides excellent exposure and achieves successful oncologic and functional outcomes. Patients requiring extensive curettage with adjuvants achieve comparable results to those treated with simple excision, offering a viable and novel surgical option for challenging cases.
- 21 March 2025
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 35 (1) , 1-9
Surgical dislocation of the hip without trochanteric osteotomy for the treatment of bone tumors around the hip
Purpose Bone tumors around the hip pose significant surgical challenges. While surgical dislocation with a trochanteric flip osteotomy through a posterior approach is commonly used, it is associated with known complications. This study is the first to report outcomes using surgical hip dislocation without a trochanteric osteotomy for this purpose. We evaluated early to long-term outcomes of this approach and compared results between patients undergoing extensive curettage with adjuvants and those undergoing simple excision. Methods Sixteen patients (18 hips) with benign or intermediate bone and synovial tumors were treated using surgical dislocation without a trochanteric flip osteotomy. Patients had a minimum follow-up of 12 months (median 3.6 years, range 1–11 years). Outcomes included local recurrence, complications, functionality, and quality of life (QoL) assessed with SF-12 (mental and physical components), HOOS, TESS, and MSTS scores. Comparative analysis was performed between extensive curettage with adjuvancy and simple excision. Results All procedures were completed successfully without any local recurrences or significant complications. Patients had a median hospital stay of 3 days (ranging from 1 to 4 days), and the median follow-up duration was 3.6 years (ranging from 1 to 13 years). The mean SF-12 physical and mental health scores were 51 and 42, respectively. Additionally, the scores for HOOS, MSTS, and TESS were 74, 77%, and 86%, respectively. One patient (6%) developed osteoarthritis, while three (17%) experienced lateral hip pain managed conservatively. No significant differences were found in complications, functionality, or QoL between the extensive curettage and simple excision groups. Conclusion Surgical dislocation of the hip without trochanteric osteotomy is a safe and effective alternative for excising tumors around the hip. It provides excellent exposure and achieves successful oncologic and functional outcomes. Patients requiring extensive curettage with adjuvants achieve comparable results to those treated with simple excision, offering a viable and novel surgical option for challenging cases.
- 4 March 2025
- Published by Springer Nature in Journal of Cancer Education
- Vol. 40 (6) , 901-912
Defining Core Competencies for Generalists in Musculoskeletal Oncology: A Latin-American Consensus for Medical Education
Inappropriate or delayed initial management of musculoskeletal neoplasms can lead to severe consequences, emphasizing the need to define core competencies for frontline practitioners. Such competencies can guide medical education and residency training objectives. This study aimed to identify core clinical competencies required by general practitioners and general orthopedic surgeons without oncologic training for the initial management of musculoskeletal tumors, with a focus on implications for medical education. A two-round modified Delphi method engaged 225 members of the Latin-American Tumor Society (SLATME) through an online questionnaire on competencies for evaluating and treating musculoskeletal tumors. Of these, 136 participated in the first round, and 111 in the second. Consensus was defined as 80% agreement on competencies being essential for the described scenarios. Consensus for all frontline practitioners included the ability to determine the need for standard or urgent referral to oncology specialists. For general orthopedic surgeons, additional competencies included performing focused anamnesis and physical exams emphasizing oncologic history, requesting and interpreting appropriate imaging and laboratory tests, and recognizing aggressive features on imaging with or without radiology input. No surgical procedure achieved strong consensus; however, there was moderate agreement that internal fixation of a pathological fracture in metastatic patients is a core competency. This study established consensus on essential evaluation competencies for frontline practitioners assessing musculoskeletal tumors. While procedural competencies for general orthopedic surgeons without oncologic training lacked consensus, the findings provide a foundation for educational priorities and guide initial patient management expectations in such settings. The results can be utilized to shape medical school curricula, residency training, and continuing medical education programs.
- 4 March 2025
- Published by Springer Nature in Journal of Cancer Education
- Vol. 40 (6) , 901-912
Defining Core Competencies for Generalists in Musculoskeletal Oncology: A Latin-American Consensus for Medical Education
Inappropriate or delayed initial management of musculoskeletal neoplasms can lead to severe consequences, emphasizing the need to define core competencies for frontline practitioners. Such competencies can guide medical education and residency training objectives. This study aimed to identify core clinical competencies required by general practitioners and general orthopedic surgeons without oncologic training for the initial management of musculoskeletal tumors, with a focus on implications for medical education. A two-round modified Delphi method engaged 225 members of the Latin-American Tumor Society (SLATME) through an online questionnaire on competencies for evaluating and treating musculoskeletal tumors. Of these, 136 participated in the first round, and 111 in the second. Consensus was defined as 80% agreement on competencies being essential for the described scenarios. Consensus for all frontline practitioners included the ability to determine the need for standard or urgent referral to oncology specialists. For general orthopedic surgeons, additional competencies included performing focused anamnesis and physical exams emphasizing oncologic history, requesting and interpreting appropriate imaging and laboratory tests, and recognizing aggressive features on imaging with or without radiology input. No surgical procedure achieved strong consensus; however, there was moderate agreement that internal fixation of a pathological fracture in metastatic patients is a core competency. This study established consensus on essential evaluation competencies for frontline practitioners assessing musculoskeletal tumors. While procedural competencies for general orthopedic surgeons without oncologic training lacked consensus, the findings provide a foundation for educational priorities and guide initial patient management expectations in such settings. The results can be utilized to shape medical school curricula, residency training, and continuing medical education programs.
- 19 January 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (1) , e263430
Long-term outcome after a limb salvage procedure using a femoral head allograft following the resection of a synovial sarcoma affecting the hindfoot
The hindfoot is an uncommon site for malignant tumours. While limb salvage procedures are now more common for treating bone sarcoma, there is limited information available on hindfoot reconstruction alternatives because of its low incidence and its challenging outcomes. We present a case report of a man in his late 60s with synovial sarcoma affecting the right heel (calcaneus and soft tissue). A wide resection was performed, followed by reconstruction using a femoral head allograft while preserving the subtalar joint and Achilles tendon insertion. Despite the partial reabsorption of the allograft at 8.4 years after surgery, excellent oncological and functional results were achieved. There are very few reports of calcaneal reconstruction following total or partial calcanectomy. Reconstructive options include the use of bone allografts, vascularized autografts, free vascularized musculocutaneous flaps and custom-made prosthesis replacement. The reconstruction technique described here, which uses an osteoarthritic femoral head allograft, is a relatively easy and widely available alternative. It has the potential functional benefits of preserving the subtalar joint and Achilles insertion if performed after a partial calcanectomy with geometric osteotomies.
- 19 January 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (1) , e263430
Long-term outcome after a limb salvage procedure using a femoral head allograft following the resection of a synovial sarcoma affecting the hindfoot
The hindfoot is an uncommon site for malignant tumours. While limb salvage procedures are now more common for treating bone sarcoma, there is limited information available on hindfoot reconstruction alternatives because of its low incidence and its challenging outcomes. We present a case report of a man in his late 60s with synovial sarcoma affecting the right heel (calcaneus and soft tissue). A wide resection was performed, followed by reconstruction using a femoral head allograft while preserving the subtalar joint and Achilles tendon insertion. Despite the partial reabsorption of the allograft at 8.4 years after surgery, excellent oncological and functional results were achieved. There are very few reports of calcaneal reconstruction following total or partial calcanectomy. Reconstructive options include the use of bone allografts, vascularized autografts, free vascularized musculocutaneous flaps and custom-made prosthesis replacement. The reconstruction technique described here, which uses an osteoarthritic femoral head allograft, is a relatively easy and widely available alternative. It has the potential functional benefits of preserving the subtalar joint and Achilles insertion if performed after a partial calcanectomy with geometric osteotomies.
- Open Access
- 25 July 2024
- Published by Acta Pediatrica de Mexico in Acta Pediátrica de México
- Vol. 45 (4) , 413-418
Tumores musculoesqueléticos en niños y adolescentes: Criterios de evaluación clínica, radiográfica y referencia
Los tumores óseos y de partes blandas son considerados como patologías poco frecuentes en la edad pediátrica; sin embargo, hasta un 18% de niños asintomáticos pueden presentar lesiones óseas benignas y tumores de partes blandas en radiografías realizadas por otra causa. Por otra parte, los sarcomas alcanzan hasta el 15% del cáncer infantil y en muchas ocasiones son diagnosticados de forma tardía o posterior a procedimientos realizados sin los cuidados oncológicos necesarios, comprometiendo su tratamiento y pronóstico.
- 25 July 2024
- Published by Acta Pediatrica de Mexico in Acta Pediátrica de México
- Vol. 45 (4) , 413-418
Open AccessTumores musculoesqueléticos en niños y adolescentes: Criterios de evaluación clínica, radiográfica y referencia
Los tumores óseos y de partes blandas son considerados como patologías poco frecuentes en la edad pediátrica; sin embargo, hasta un 18% de niños asintomáticos pueden presentar lesiones óseas benignas y tumores de partes blandas en radiografías realizadas por otra causa. Por otra parte, los sarcomas alcanzan hasta el 15% del cáncer infantil y en muchas ocasiones son diagnosticados de forma tardía o posterior a procedimientos realizados sin los cuidados oncológicos necesarios, comprometiendo su tratamiento y pronóstico.
- 4 May 2024
- Published by Springer Nature
- p. 2103-2117
Benign Bone Tumors